205 related articles for article (PubMed ID: 21352603)
1. Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts.
Meng W; Xia Q; Wu L; Chen S; He X; Zhang L; Gao Q; Zhou H
BMC Cancer; 2011 Feb; 11():88. PubMed ID: 21352603
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
[TBL] [Abstract][Full Text] [Related]
3. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
Deng X; Bellis S; Yan Z; Friedman E
Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
[TBL] [Abstract][Full Text] [Related]
4. [Functional significance of TGF-beta1 signal transduction pathway in oral squamous cell carcinoma].
Wang XM; Liu CM; Zhang CR; Xu XG; Fu SB
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):28-32. PubMed ID: 19538865
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.
Wang X; Sun W; Bai J; Ma L; Yu Y; Geng J; Qi J; Shi Z; Fu S
Mol Biol Rep; 2009 May; 36(5):861-9. PubMed ID: 18418730
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts regulate keratinocyte cell-cell adhesion via TGF-β-dependent pathways in genotype-specific oral cancer.
Cirillo N; Hassona Y; Celentano A; Lim KP; Manchella S; Parkinson EK; Prime SS
Carcinogenesis; 2017 Jan; 38(1):76-85. PubMed ID: 27803052
[TBL] [Abstract][Full Text] [Related]
7. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
Tazat K; Hector-Greene M; Blobe GC; Henis YI
Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
[TBL] [Abstract][Full Text] [Related]
8. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
McLean S; Di Guglielmo GM
Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
[TBL] [Abstract][Full Text] [Related]
9. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of transforming growth factor type III receptor restores TGF-β1 sensitivity in human tongue squamous cell carcinoma cells.
Li D; Xu D; Lu Z; Dong X; Wang X
Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26205654
[TBL] [Abstract][Full Text] [Related]
11. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
12. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
13. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1/TβRII/Smad3 signaling pathway promotes VEGF expression in oral squamous cell carcinoma tumor-associated macrophages.
Sun H; Miao C; Liu W; Qiao X; Yang W; Li L; Li C
Biochem Biophys Res Commun; 2018 Mar; 497(2):583-590. PubMed ID: 29462614
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of type III TGF-β receptor aggravates lung fibrotic process.
Ahn JY; Park S; Yun YS; Song JY
Biomed Pharmacother; 2010 Sep; 64(7):472-6. PubMed ID: 20359848
[TBL] [Abstract][Full Text] [Related]
16. A systems biology approach identifies effective tumor-stroma common targets for oral squamous cell carcinoma.
Meng W; Wu Y; He X; Liu C; Gao Q; Ge L; Wu L; Liu Y; Guo Y; Li X; Liu Y; Chen S; Kong X; Liang Z; Zhou H
Cancer Res; 2014 Apr; 74(8):2306-15. PubMed ID: 24556718
[TBL] [Abstract][Full Text] [Related]
17. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
[TBL] [Abstract][Full Text] [Related]
18. A novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive phenotype of oral squamous cell carcinoma via enhanced EGFR signaling.
Son HK; Kim D; Lim Y; Kim J; Park I
BMC Cancer; 2020 Nov; 20(1):1163. PubMed ID: 33246423
[TBL] [Abstract][Full Text] [Related]
19. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin.
Li YY; Zhou CX; Gao Y
Exp Cell Res; 2018 Aug; 369(1):43-53. PubMed ID: 29719198
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]